drugset / Trial / NCT06419543

Paradoxical Reactions of Remimazolam in Pediatric Painless Gastrointestinal Endoscopy

NCT06419543

Completed 333 enrolled Tongji Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Exploring the effect of remimazolam dose on paradoxical reactions in pediatric painless gastrointestinal endoscopy.

Timeline

Start
2024-05-20
Primary completion
2024-10-01
Completion
2024-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Remimazolam Small molecule 0.1 mg/kg
Subject Remimazolam Small molecule 0.2 mg/kg
Subject Remimazolam Small molecule 0.3 mg/kg

Indications

No indication recorded.